We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.54B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+22.19%
3 Year Est. Return
+76.82%
5 Year Est. Return
+87.33%
10 Year Est. Return
+300.59%
AUM
$2.48B
AUM Growth
-$34.4M
Cap. Flow
-$68.7M
Cap. Flow %
-2.77%
Top 10 Hldgs %
37.3%
Holding
187
New
3
Increased
37
Reduced
75
Closed
7

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.23M
2
LLY icon
Eli Lilly
LLY
+$431K
3
ABT icon
Abbott
ABT
+$312K
4
EXEL icon
Exelixis
EXEL
+$227K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$226K

Sector Composition

Rank Sector Weight
1 Technology 26.97%
2 Financials 13.87%
3 Healthcare 11.95%
4 Communication Services 10.39%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETN icon
26
Eaton
ETN
$155B
$31.6M 1.27%
95,244
-1,530
-2% -$537K
SCHA icon
27
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$31.3M 1.26%
1,211,020
-115,944
-9% -$3.08M
CB icon
28
Chubb
CB
$137B
$29.9M 1.21%
108,237
-820
-0.8% -$233K
CL icon
29
Colgate-Palmolive
CL
$74.4B
$28.5M 1.15%
313,516
-6,050
-2% -$577K
PYPL icon
30
PayPal
PYPL
$49.9B
$28.5M 1.15%
333,685
-2,640
-0.8% -$222K
MRK icon
31
Merck
MRK
$315B
$27.9M 1.13%
280,856
+1,658
+0.6% +$171K
VMC icon
32
Vulcan Materials
VMC
$37.4B
$27.8M 1.12%
108,207
-782
-0.7% -$210K
SYK icon
33
Stryker
SYK
$123B
$27.8M 1.12%
77,169
-319
-0.4% -$118K
NOW icon
34
ServiceNow
NOW
$106B
$27.6M 1.11%
129,980
-2,065
-2% -$418K
HD icon
35
Home Depot
HD
$338B
$27.1M 1.09%
69,742
-362
-0.5% -$148K
BN icon
36
Brookfield
BN
$107B
$26.9M 1.08%
702,266
-3,979
-0.6% -$150K
AMT icon
37
American Tower
AMT
$79.2B
$25.5M 1.03%
138,774
-883
-0.6% -$183K
STZ icon
38
Constellation Brands
STZ
$22.7B
$25.4M 1.02%
114,808
+159
+0.1% +$37.8K
ACN icon
39
Accenture
ACN
$87.9B
$22.4M 0.9%
63,680
+1
+0% +$360
FTV icon
40
Fortive
FTV
$18.8B
$22M 0.89%
389,773
-214
-0.1% -$12.3K
ROP icon
41
Roper Technologies
ROP
$36.6B
$20.5M 0.82%
39,351
+144
+0.4% +$79K
SBUX icon
42
Starbucks
SBUX
$120B
$20.3M 0.82%
222,755
-1,088
-0.5% -$105K
PLD icon
43
Prologis
PLD
$140B
$20M 0.81%
189,567
+1,896
+1% +$218K
DD icon
44
DuPont de Nemours
DD
$18.3B
$19.4M 0.78%
202,545
+257
+0.1% +$26.7K
ZS icon
45
Zscaler
ZS
$24.2B
$17M 0.68%
94,162
+136
+0.1% +$26.3K
MA icon
46
Mastercard
MA
$480B
$17M 0.68%
32,231
-258
-0.8% -$134K
MDLZ icon
47
Mondelez International
MDLZ
$78.3B
$16.4M 0.66%
273,963
+319
+0.1% +$21.1K
MMM icon
48
3M
MMM
$83.4B
$15.6M 0.63%
121,136
-90
-0.1% -$11.8K
META icon
49
Meta Platforms (Facebook)
META
$1.64T
$15.6M 0.63%
26,600
-70
-0.3% -$41.1K
SHEL icon
50
Shell
SHEL
$242B
$15M 0.61%
240,120
+1,074
+0.4% +$70.4K

Similar funds

Klingenstein Fields & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Klingenstein Fields & Co held 187 positions worth $2.48B, down 1.4% from $2.52B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q4 2024 filing shows 3 new, 37 increased, 75 reduced and 7 closed positions. Its largest new stake was Exelixis: 7,000 shares worth $233K. The largest sale was Schwab International Equity ETF, an estimated $15.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Klingenstein Fields & Co's largest Q4 2024 buy was Exelixis: 7,000 shares worth $233K.
  • Klingenstein Fields & Co added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $5.23M increase.
  • Klingenstein Fields & Co's biggest Q4 2024 reduction was Schwab International Equity ETF, cutting an estimated $15.5M.
  • Klingenstein Fields & Co fully exited First Trust Long/Short Equity ETF in Q4 2024, selling an estimated $2.04M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.48B portfolio in Q4 2024.
  • Klingenstein Fields & Co opened 3 new positions and closed 7 in Q4 2024.
  • Klingenstein Fields & Co's portfolio value fell 1.4% quarter-over-quarter to $2.48B.

Based on Klingenstein Fields & Co's 13F filing for Q4 2024, filed 30 Jan 2025.